candesartan has been researched along with Active Hyperemia in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both candesartan and perindopril can prevent FFA-induced myocardial microcirculatory dysfunction during hyperemia via modulation of leukocyte activation and microvascular endothelial function." | 3.88 | Renin-Angiotensin System Inhibitors Can Prevent Intravenous Lipid Infusion-Induced Myocardial Microvascular Dysfunction and Leukocyte Activation. ( Kikuchi, Y; Kobayashi, M; Momomura, S; Mutoh, A; Ueda, S; Wada, H; Yasu, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasu, T | 1 |
| Mutoh, A | 1 |
| Wada, H | 1 |
| Kobayashi, M | 1 |
| Kikuchi, Y | 1 |
| Momomura, S | 1 |
| Ueda, S | 1 |
1 other study available for candesartan and Active Hyperemia
| Article | Year |
|---|---|
Renin-Angiotensin System Inhibitors Can Prevent Intravenous Lipid Infusion-Induced Myocardial Microvascular Dysfunction and Leukocyte Activation.
Topics: Adult; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Cross-Over Studies; Double-Blind Me | 2018 |